# VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN)

> **NCT05834673** · NA · TERMINATED · sponsor: **Monash University** · enrollment: 6 (actual)

## Conditions studied

- Atherosclerotic Cardiovascular Disease (ASCVD)
- Coronary Heart Disease (CHD)
- Cerebrovascular Disease
- Peripheral Arterial Disease (PAD)

## Interventions

- **OTHER:** SMS messages
- **OTHER:** Telephone-based support calls
- **OTHER:** GP Education

## Key facts

- **NCT ID:** NCT05834673
- **Lead sponsor:** Monash University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-11-17
- **Primary completion:** 2024-12-19
- **Final completion:** 2024-12-19
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Loss of strategic interest by the funding party. The participants' recruitment rate failed to meet the target within the pre-specified recruitment windows.
- **Last updated:** 2025-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05834673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05834673, "VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05834673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*